Fate Therapeutics (FATE) Scheduled to Post Earnings on Wednesday

Fate Therapeutics (NASDAQ:FATE – Get Rating) will release its earnings data after the market closes on Wednesday, May 3rd. Analysts expect Fate Therapeutics to post earnings of ($0.55) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link. Fate Therapeutics (NASDAQ:FATE – Get […]

Related Keywords

Leonard Zon ,Rudolf Jaenisch ,Philip Beachy ,Scott Wolchko ,Piper Sandler ,David Scadden ,Alexander Rives ,Michael Rudnicki ,Raymond James Associates ,Redmile Group Llc ,Securities Exchange Commission ,Financial Services Group Inc ,Fate Therapeutics Inc ,Hightower Advisors ,Envestnet Asset Management Inc ,Advisor Group ,Fate Therapeutics ,Get Rating ,Director Redmile Group ,Exchange Commission ,Asset Management ,Tower Advisors ,Services Group ,Sheng Ding ,Fate Therapeutics Daily ,Nasdaq Fate ,Fate ,Medical ,Earnings ,